Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ADAM33	"C20orf153, dJ964F7.1, DKFZp434K0521"	ENSG00000149451	"ADAM metallopeptidase domain 33"	Q9BZ11	20	3667965-3682246	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 55.7;smooth muscle: 58.0"	"Cell type enhanced"	"Detected in some"	12	"Fibroblasts: 23.2;Leydig cells: 21.0;Peritubular cells: 9.6;Smooth muscle cells: 15.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 31.3;ASC TERT1: 40.6;BJ: 13.8;BJ hTERT+: 23.7;fHDF/TERT166: 14.1;U-2197: 18.9"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Low region specificity"	"Detected in all"			"HPA067152, HPA071758"	Approved		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA067152: AB_2685791, HPA071758: "	"unprognostic (1.10e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.39e-3)"	"unprognostic (7.43e-4)"	"unprognostic (7.14e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.75e-11)"	"unprognostic (1.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-5)"	"unprognostic (3.10e-3)"	10.0	1.5	4.6	9.2	2.6	0.0	20.2	2.8	2.7	55.7	29.5	2.2	20.9	4.7	44.3	12.3	17.0	16.9	17.5	5.3	5.0	0.9	0.9	0.5	3.6	2.2	4.9	3.0	11.8	1.6	0.0	1.6	5.4	7.0	22.8	5.5	3.7	4.2	27.1	3.5	4.8	9.1	58.0	3.3	1.9	9.9	5.4	3.5	0.1	4.0	10.1	2.0	24.9	36.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.3	40.6	0.1	13.8	23.7	4.1	8.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	6.9	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.1	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.6	2.6	2.8	2.7	5.0	0.9	4.9	3.0	7.0	3.5	0.0	0.0	0.0	0.1	4.8	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.2	23.2	0.2	0.0	0.0	0.5	0.0	0.0	3.1	0.0	0.0	21.0	0.6	3.3	0.0	0.0	3.3	0.0	0.0	9.6	0.0	0.0	6.5	15.1	0.6	0.5	2.8	0.5	0.0	0.0	0.0
AL669918.1		ENSG00000250264			6	32813767-32838822	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 17.2;HDLM-2: 11.4;HEL: 12.4"									HPA001312	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Nuclear speckles, Endoplasmic reticulum"		"HPA001312: AB_1080206"	"unprognostic (6.13e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.62e-1)"		"unprognostic (9.88e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.33e-1)"	6.5	3.6	2.8	25.5	3.1	3.8	3.6	3.1	3.3	4.8	7.7	3.5	1.0	5.7	4.6	2.5	4.8	3.6	5.7	3.5	2.1	2.6	5.3	10.0	8.5	12.6	3.2	2.8	4.7	2.1	1.7	5.0	2.4	3.6	3.8	3.1	3.6	7.0	1.4	2.5	3.3	15.1	2.7	2.8	18.1	12.3	2.5	3.1	14.0	7.5	3.2	10.6	3.8	3.9	8.6	5.5	8.1	4.8	2.3	4.6	5.1	2.1	3.2	0.0	0.7	1.6	1.7	0.5	0.6	0.3	0.0	0.6	0.0	3.3	17.2	2.0	0.2	0.2	7.8	1.6	1.7	0.6	11.4	0.2	12.4	2.1	0.3	0.5	0.0	0.5	0.0	0.9	0.5	0.2	0.0	0.0	1.9	3.1	2.9	0.2	0.6	1.4	0.9	0.2	0.0	2.9	6.0	0.6	5.5	0.0	0.0	0.3	0.3	0.5	5.3	1.4	0.0	5.1	1.3	0.0	1.3	1.9	0.4	0.7	1.4	2.8	7.6	0.7	3.6	0.4	1.6	3.1	6.1	3.5	3.2	3.4	8.0	2.8	3.9	5.5	8.6	2.1	4.6	8.1	2.3	4.8	5.2	4.2	5.1	2.8	3.1	3.1	3.3	2.1	2.6	3.2	2.8	3.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996065-7010736	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 1.8;Suprabasal keratinocytes: 1.0;Urothelial cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"A-431: 17.5;HEL: 28.0"	"Region enriched"	"Detected in single"	5	"olfactory region: 5.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		5800000	Cytosol	"Nuclear speckles, Vesicles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	0.3	0.6	0.3	1.5	0.4	2.0	0.3	0.3	1.0	28.6	0.4	0.3	0.3	0.7	3.4	0.5	28.4	0.4	1.6	0.8	0.3	0.1	0.3	0.3	0.5	1.9	0.5	0.3	0.4	0.8	0.0	0.3	0.7	0.4	0.3	0.0	0.4	8.1	0.3	0.5	12.8	0.8	0.3	0.3	1.5	0.3	0.6	0.3	0.3	0.8	22.7	9.5	1.2	42.7	1.1	1.3	4.8	0.9	0.7	0.8	14.3	17.5	2.9	1.3	1.0	0.0	0.0	1.2	1.1	0.0	0.0	0.0	2.6	0.6	0.9	0.6	0.0	1.0	2.2	0.0	0.1	0.0	1.9	2.3	28.0	3.9	1.9	0.1	0.2	4.6	0.0	0.0	0.0	0.0	1.7	0.0	1.9	1.8	1.0	0.0	0.2	0.3	0.6	0.9	0.1	0.6	1.0	0.6	0.4	0.0	2.2	0.1	0.6	0.5	0.6	0.2	1.8	1.0	0.7	3.2	1.5	0.9	1.5	0.7	0.5	0.2	0.5	0.9	2.1	0.7	1.8	0.9	1.7	0.7	0.5	0.5	1.1	0.5	0.8	0.7	0.7	0.2	0.4	4.8	0.7	0.4	1.3	0.3	14.3	0.3	0.4	0.3	0.6	0.3	0.1	0.5	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	1.7
ATP6V0A1	"a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1"	ENSG00000033627	"ATPase H+ transporting V0 subunit a1"	Q93050	17	42458844-42522611	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.2;parathyroid gland: 65.6"	"Cell type enhanced"	"Detected in all"	8	"Cone photoreceptor cells: 276.9;Rod photoreceptor cells: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022144	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Vesicles,Cytosol"		NA	NA		21000	"Golgi apparatus, Vesicles"	"Nuclear speckles, Cytosol"	"HPA022144: AB_1845189"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (3.07e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (6.90e-4)"	9.4	15.6	19.3	9.3	46.1	9.9	9.1	55.8	66.2	8.0	11.6	25.8	5.1	17.9	11.4	11.1	9.6	9.7	12.2	9.9	23.8	32.8	20.3	11.3	12.7	6.6	23.6	24.8	11.4	9.3	65.6	23.6	11.2	43.3	9.9	11.3	19.7	8.2	10.7	28.9	14.7	12.4	11.7	23.7	11.1	8.8	9.8	13.1	5.2	16.3	6.7	7.8	6.7	6.9	6.3	9.1	14.2	10.5	0.1	2.8	4.2	6.6	13.8	8.5	15.2	14.2	12.4	4.9	4.7	8.8	10.1	13.3	8.8	15.0	1.2	8.7	9.7	13.9	14.5	13.0	8.0	11.8	10.3	13.6	10.7	10.4	6.9	8.8	4.6	19.6	9.1	11.6	16.2	6.9	12.6	7.1	5.0	38.9	42.3	15.0	5.7	1.8	4.1	5.4	8.8	0.1	0.1	8.8	18.6	11.7	5.3	23.4	12.4	7.3	6.7	14.0	11.5	16.3	7.0	4.2	8.6	0.3	12.6	5.6	17.2	23.4	2.5	11.5	0.1	10.0	12.1	10.5	8.0	0.8	3.4	1.2	3.5	0.6	0.1	9.1	6.3	1.0	0.8	14.2	0.1	2.4	4.7	2.8	4.2	19.3	46.1	55.8	65.9	23.8	32.8	23.6	24.8	43.3	13.1	17.9	46.6	27.3	45.1	17.5	158.7	19.5	30.6	6.7	14.8	14.0	276.9	26.4	10.0	14.7	2.4	19.2	44.6	46.7	15.8	13.4	33.9	38.7	23.1	33.6	46.0	90.6	81.5	19.6	33.1	3.1	16.1	25.8	38.8	3.6	23.1	51.9	17.6	38.6	22.3	28.4	349.7	6.5	48.9	38.7	18.5	17.7	83.5	4.4	19.5	10.7
BCL2L2-PABPN1		ENSG00000258643	"BCL2L2-PABPN1 readthrough"	Q92843	14	23306835-23325369	"Cancer-related genes, Predicted intracellular proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.8;Ciliated cells: 8.1;Club cells: 2.3;granulocytes: 2.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 21.5;BJ hTERT+ SV40 Large T+ RasG12V: 23.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000637, HPA048740"	Approved		Uncertain	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA000637: AB_1079553, HPA048740: "	"unprognostic (1.32e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-3)"	"unprognostic (9.82e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.05e-6)"	"unprognostic (4.39e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.84e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.72e-7)"	"unprognostic (3.13e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.46e-3)"	"unprognostic (4.95e-2)"	11.4	5.3	14.2	5.8	17.7	12.0	17.7	16.4	24.2	17.9	21.0	14.4	11.4	4.5	13.7	6.9	14.4	16.1	16.0	11.2	17.8	9.5	7.1	6.9	10.3	6.4	13.1	21.2	8.0	21.4	29.1	11.4	18.0	17.5	16.3	5.6	7.5	22.1	37.7	7.0	14.5	7.7	18.6	20.2	9.7	13.0	15.0	14.8	0.0	14.4	5.7	5.4	16.6	12.1	1.9	1.1	2.1	4.4	3.5	0.3	1.1	5.1	6.6	4.2	3.4	0.3	9.6	3.3	1.4	13.8	21.5	23.4	5.4	16.8	1.7	1.2	7.2	5.2	7.3	4.8	6.6	5.6	3.5	5.3	0.4	0.9	8.7	2.9	1.8	10.4	8.7	12.2	7.9	1.5	1.7	5.1	0.1	1.6	5.1	6.5	7.9	0.2	1.1	5.3	1.0	4.2	3.2	0.1	1.1	3.7	2.1	7.0	2.8	2.1	7.1	1.9	0.7	3.8	2.8	1.9	5.6	4.4	5.5	3.6	2.8	2.6	0.5	2.3	3.8	8.6	2.1	4.4	0.3	0.2	1.6	0.2	1.4	0.0	0.0	0.6	1.9	0.3	0.1	0.8	3.5	2.6	1.1	0.0	1.1	14.2	17.7	16.4	24.2	17.8	9.5	13.1	21.2	17.5	14.8	3.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	8.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
C16orf71	"DKFZp686H2240, FLJ43261"	ENSG00000166246	"Chromosome 16 open reading frame 71"	Q8IYS4	16	4734272-4749396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"fallopian tube: 14.1;testis: 48.9"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 18.7;Early spermatids: 20.4;Late spermatids: 45.3;Spermatocytes: 48.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 7.6;U-2197: 8.3"									HPA049468	Enhanced		Uncertain	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA049468: AB_2680779"	"unprognostic (1.24e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.79e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.54e-5)"	"unprognostic (1.65e-1)"	0.3	0.5	0.7	0.3	1.9	0.0	0.3	1.0	1.0	0.9	0.3	2.4	0.6	0.2	0.6	2.5	0.4	14.1	0.8	0.3	1.1	1.0	1.0	1.1	1.7	0.1	0.7	0.5	1.2	0.4	0.8	1.7	0.1	3.6	0.5	0.1	0.4	1.3	1.1	0.4	0.2	0.3	0.4	0.5	0.2	0.3	48.9	0.7	0.2	1.1	0.0	0.4	0.3	0.5	1.4	4.1	0.0	1.1	0.0	0.7	0.4	0.6	3.3	0.7	1.9	4.4	1.9	1.4	1.8	1.6	1.5	1.9	1.5	1.4	0.1	1.8	2.7	4.4	1.5	1.7	1.7	0.3	0.7	1.1	0.4	2.4	0.1	1.4	1.4	0.6	0.5	0.4	5.8	1.6	1.1	0.8	1.3	1.1	0.9	1.5	7.6	0.4	1.2	1.0	2.1	1.6	0.5	0.8	2.2	4.0	0.7	4.9	1.8	1.8	1.5	0.6	1.3	6.7	0.4	0.6	1.2	1.4	8.3	0.9	3.3	2.6	0.8	0.7	0.4	1.3	0.0	0.7	0.0	0.2	0.2	0.0	0.0	0.7	0.1	0.9	1.4	0.4	0.5	0.0	0.0	1.1	4.1	0.0	0.4	0.7	1.9	1.0	1.0	1.1	1.0	0.7	0.5	3.6	0.7	0.0	0.6	0.0	0.2	0.0	0.8	0.8	0.0	18.7	5.7	0.0	3.9	0.2	0.0	0.5	20.4	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	45.3	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.4	1.3	1.7	0.0	0.0	48.1	6.6	0.0	0.1	0.0	0.0	0.0
C1orf194		ENSG00000179902	"Chromosome 1 open reading frame 194"	Q5T5A4	1	109105951-109113857	"Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 36.5;fallopian tube: 60.2;testis: 77.6"	"Group enriched"	"Detected in some"	10	"Ciliated cells: 776.3;Early spermatids: 1757.0;Late spermatids: 2679.4"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8"	"Region enriched"	"Detected in many"	5	"pons and medulla: 36.5"	"Cell type enriched"	"Detected in some"	5	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in some"		"AF22: 4.5;RPTEC TERT1: 1.1;SCLC-21H: 6.3;U-87 MG: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031144, HPA049684"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA031144: AB_10602109, HPA049684: AB_2680849"	"unprognostic (9.91e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.91e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.98e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.08e-6)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.27e-3)"	0.3	0.4	1.5	0.3	6.8	0.3	0.4	0.3	2.6	1.8	0.3	12.3	0.0	0.4	1.0	11.1	0.4	60.2	0.3	0.3	3.0	1.6	0.3	0.3	7.5	0.4	0.5	1.8	10.3	0.7	0.4	2.7	0.3	36.5	0.4	0.4	0.0	0.3	0.3	0.3	0.3	0.4	0.4	0.7	0.3	0.5	77.6	2.3	0.0	0.5	0.0	0.3	0.5	0.2	0.2	0.0	5.3	0.0	0.0	0.3	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	6.3	0.3	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	6.8	0.3	2.6	3.0	1.6	0.5	1.8	36.5	2.3	0.0	2.6	0.0	0.2	0.0	0.6	2.0	0.0	776.3	56.9	0.0	0.0	0.0	0.0	0.0	1757.0	0.0	0.0	0.0	0.2	0.0	0.2	1.6	3.5	0.0	0.1	0.0	0.0	0.0	0.0	2679.4	19.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	17.7	0.0	0.0	6.5	0.0	176.3	13.0	0.1	0.0	0.0	0.0	0.0
CKAP4	"CLIMP-63, ERGIC-63, P63"	ENSG00000136026	"Cytoskeleton associated protein 4"	Q07065	12	106237877-106304279	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 34.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 34.6"	"Cell line enhanced"	"Detected in many"		"BJ: 74.6;BJ hTERT+: 94.1;fHDF/TERT166: 112.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000278, HPA000792, HPA001225"	Enhanced		Uncertain	"Nuclear speckles,Cytosol,Cytoplasmic bodies"		NA	NA		11000	"Nuclear speckles, Cytosol"	"Cytoplasmic bodies"	"HPA000278: AB_1078527, HPA000792: AB_1078526, HPA001225: AB_2666241"	"unprognostic (5.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (6.61e-5)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (5.02e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.20e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.66e-2)"	13.0	23.8	7.1	15.3	4.9	39.5	27.2	6.9	8.4	42.3	19.2	6.5	24.8	8.1	23.7	35.2	47.3	17.2	26.6	32.9	5.7	8.0	18.3	42.1	22.2	28.5	6.3	5.4	28.6	55.2	12.7	12.0	30.6	6.8	23.9	20.5	13.2	34.4	28.0	11.1	20.8	10.7	20.4	5.8	16.7	23.0	10.3	4.2	4.0	18.6	30.0	27.8	25.8	21.4	4.2	2.3	34.6	7.5	0.1	1.0	2.4	11.4	14.4	17.5	18.9	34.1	30.4	10.1	74.6	94.1	36.5	42.0	6.1	2.6	0.7	13.6	112.3	12.4	20.8	12.7	11.3	26.3	0.4	7.4	0.0	8.3	11.9	25.4	0.1	0.2	29.1	15.5	30.9	22.4	46.3	42.6	0.8	0.0	1.5	34.6	3.8	0.5	0.4	10.1	6.0	17.5	5.3	12.6	0.9	11.1	10.3	5.7	6.4	13.2	9.0	7.1	16.4	10.1	5.2	36.3	28.8	15.9	11.9	21.0	4.0	0.0	8.1	20.7	1.4	25.1	34.6	7.5	8.7	0.5	2.7	0.7	4.2	0.7	0.4	2.3	1.6	1.0	0.9	12.7	0.1	4.1	0.0	0.2	2.4	7.1	4.9	6.9	8.4	5.7	8.0	6.3	5.4	6.8	4.2	20.8	24.5	3.0	33.7	48.7	12.8	42.1	43.3	5.3	21.6	22.7	9.8	24.4	5.0	32.4	0.9	24.8	13.4	0.0	75.4	79.1	87.2	68.6	19.5	49.1	19.2	44.5	39.7	49.7	37.3	1.1	63.3	14.9	32.1	6.4	162.0	23.7	51.4	5.8	57.7	9.1	18.4	12.9	46.7	2.5	12.2	62.9	22.1	3.2	60.8	36.8
DSTYK	"DustyPK, KIAA0472, RIP5, RIPK5"	ENSG00000133059	"Dual serine/threonine and tyrosine protein kinase"	Q6XUX3	1	205142505-205211566	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Horizontal cells: 84.2;Melanocytes: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044140	Approved		Uncertain	"Nuclear speckles,Intermediate filaments,Cytosol"		NA	NA			"Nuclear speckles, Intermediate filaments"	Cytosol	"HPA044140: AB_10965031"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (8.73e-5)"	6.4	9.2	13.8	4.4	13.3	19.6	8.2	20.4	16.4	8.4	6.5	6.8	4.2	3.3	10.5	7.4	6.7	9.2	5.4	5.7	10.7	9.0	9.3	2.5	7.3	5.4	8.1	11.8	14.0	5.9	22.0	11.0	7.1	12.2	7.2	4.6	9.2	6.2	8.8	14.6	14.0	4.8	8.8	11.0	7.0	5.3	11.5	9.2	7.1	8.4	3.6	5.3	7.6	6.4	3.5	3.1	9.8	3.5	4.8	5.1	1.6	6.9	4.5	4.9	5.9	7.1	12.0	3.4	8.7	8.7	9.1	6.2	2.0	3.8	5.1	2.6	14.6	5.0	4.9	5.3	5.6	9.3	2.4	5.7	9.3	6.0	2.2	6.4	2.6	5.0	7.0	8.5	9.3	8.9	10.9	6.6	3.7	12.0	3.5	7.2	4.7	2.0	2.3	5.2	1.3	5.4	1.8	8.8	4.5	6.1	4.4	2.7	5.3	7.4	7.7	24.3	5.9	5.6	3.4	6.6	5.7	5.7	8.6	5.7	3.6	2.5	3.0	6.6	3.6	20.3	9.8	3.5	6.0	4.6	2.5	4.3	2.7	3.4	3.8	3.1	3.5	5.1	3.7	5.1	4.8	1.8	2.3	2.0	1.6	13.8	13.3	20.4	16.4	10.7	9.0	8.1	11.8	12.2	9.2	26.8	13.3	11.1	5.8	13.3	46.4	9.5	12.7	29.4	17.0	15.7	31.4	5.9	5.0	10.9	8.6	14.9	3.2	23.3	7.8	4.9	18.1	8.2	23.1	7.4	7.8	84.2	12.2	24.5	20.2	17.3	15.3	13.1	86.0	10.0	5.8	50.7	8.5	3.5	17.0	6.2	34.9	25.8	12.0	20.0	12.7	12.2	2.2	14.9	7.6	5.6
DUSP28	"DUSP26, VHP"	ENSG00000188542	"Dual specificity phosphatase 28"	Q4G0W2	2	240560054-240564014	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047456, CAB069448"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB069448: , HPA047456: AB_10961145"	"unprognostic (1.88e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.71e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-3)"	1.8	2.8	2.7	3.0	3.4	7.9	3.5	6.3	3.7	3.1	2.6	3.3	6.5	2.9	2.6	5.0	3.5	3.1	4.4	16.3	2.8	2.7	3.2	3.4	2.5	6.1	3.5	2.4	2.6	10.2	2.6	5.0	3.2	2.8	4.3	2.8	2.7	3.7	2.4	21.2	4.9	4.2	4.3	2.2	5.9	4.2	8.2	2.3	2.6	4.4	13.4	4.2	2.8	4.5	3.8	3.3	10.7	2.1	2.7	3.3	2.0	1.7	1.6	2.2	2.6	1.4	0.8	2.4	1.9	1.2	1.5	1.1	1.0	4.5	2.7	1.0	1.2	2.3	5.1	1.7	0.7	1.6	3.4	6.4	3.9	3.4	2.5	1.0	2.5	6.7	1.7	1.8	1.0	1.3	2.9	0.7	3.9	2.7	3.3	1.3	1.9	3.1	4.0	1.4	2.6	1.4	3.8	4.8	3.6	1.1	2.9	4.9	2.7	1.8	1.9	2.2	1.4	2.4	4.4	1.7	3.5	2.9	2.2	1.7	13.2	3.8	4.4	2.2	1.9	2.8	10.7	2.1	0.7	2.7	1.4	3.0	2.1	2.8	2.8	1.2	3.8	3.3	3.0	3.6	2.7	1.5	3.3	2.2	2.0	2.7	3.4	6.3	3.6	2.8	2.7	3.5	2.4	2.8	2.3	0.0	5.0	5.1	6.9	3.3	6.3	12.9	12.7	6.7	1.2	12.2	3.9	6.4	13.3	4.1	27.6	3.1	11.8	0.0	5.1	4.0	4.1	8.4	6.9	6.6	10.0	7.9	8.1	2.5	10.3	29.8	2.8	7.0	6.8	8.2	8.1	7.4	3.9	11.8	1.4	11.2	6.6	6.5	5.6	41.1	17.6	4.6	5.8	12.5	10.1	6.8
EPHB6	HEP	ENSG00000106123	"EPH receptor B6"		7	142855061-142871094	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 30.1;lymphoid tissue: 26.7;skin 1: 32.1"	"Cell type enhanced"	"Detected in many"	16	"Muller glia cells: 270.3;Sertoli cells: 103.5;Suprabasal keratinocytes: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"MOLT-4: 18.2;RT4: 34.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035784			Uncertain	"Nuclear speckles"	"Intracellular and membrane"	NA	NA			"Nuclear speckles"		"HPA035784: AB_2674781"	"unprognostic (1.90e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (7.08e-3)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (2.53e-3)"	"unprognostic (3.15e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (4.68e-5)"	3.3	1.7	7.4	3.0	30.1	3.3	2.6	3.1	29.3	9.0	1.5	0.8	3.4	0.9	3.0	4.5	7.5	6.4	2.8	1.4	5.4	4.2	1.7	1.3	2.4	3.6	3.3	14.4	3.9	7.8	0.8	1.1	2.9	1.7	6.8	0.9	1.5	4.7	8.1	1.8	32.1	1.6	2.0	1.4	2.6	3.3	3.8	3.6	26.7	6.6	2.5	3.3	5.1	6.5	4.1	0.9	1.0	1.3	0.0	3.1	1.4	0.1	0.0	0.0	0.4	2.0	1.0	0.0	0.2	0.4	0.1	0.0	0.6	1.3	0.0	0.0	0.1	0.0	4.5	0.2	0.0	0.0	1.0	0.1	0.3	0.0	0.2	0.6	4.3	0.2	0.3	0.0	1.2	0.0	0.0	0.2	3.0	0.6	0.0	0.0	0.0	18.2	3.3	3.1	0.7	1.3	0.4	0.0	0.0	0.0	34.6	0.0	0.0	1.2	0.9	0.0	0.4	2.9	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	1.3	0.5	0.1	1.0	0.6	4.1	2.5	1.4	0.9	1.0	3.1	1.5	1.0	0.0	0.4	0.1	1.9	1.4	7.4	30.1	3.1	29.3	5.4	4.2	3.3	14.4	1.7	3.6	3.0	1.7	4.5	25.1	48.3	4.3	2.0	38.2	6.7	10.3	7.0	2.0	0.2	5.0	25.0	0.7	1.4	0.0	0.0	5.7	0.0	12.3	11.7	0.0	1.8	4.3	0.0	1.7	1.3	11.5	4.0	27.9	5.3	11.8	0.0	0.0	270.3	19.6	0.0	9.2	0.4	5.0	103.5	18.4	0.2	8.3	103.5	0.2	8.3	0.0	23.4
EPOR		ENSG00000187266	"Erythropoietin receptor"	P19235	19	11377205-11384342	"Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted membrane proteins"		Receptor	"Cancer-related genes, Congenital erythrocytosis, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 70.0;Ito cells: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA077654			Supported	"Nuclear speckles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA077654: "	"unprognostic (9.13e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (9.00e-2)"	"prognostic favorable (3.17e-5)"	"unprognostic (6.37e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.01e-3)"	5.5	8.6	2.1	1.1	2.9	14.7	2.6	1.3	1.7	3.9	3.3	2.8	13.3	1.0	3.6	11.6	2.4	3.2	1.8	11.2	1.9	1.4	12.1	8.4	8.5	6.9	1.9	1.6	1.9	9.2	28.1	5.2	12.7	2.3	3.1	1.4	3.3	8.7	18.3	2.0	1.1	1.7	1.5	4.0	8.0	3.7	2.2	1.0	1.6	21.5	1.0	1.5	1.9	2.1	2.6	2.5	12.2	7.7	0.9	4.8	2.9	3.5	1.2	3.5	4.1	5.4	3.4	2.1	2.2	6.8	3.6	4.6	1.2	1.3	2.4	3.9	4.0	5.0	0.9	2.7	1.4	4.2	2.0	1.6	13.1	1.1	2.0	3.8	2.7	5.5	2.5	0.5	4.8	3.3	8.4	8.3	5.1	11.6	11.7	4.0	3.1	2.5	3.3	1.9	1.9	9.4	6.7	6.0	5.3	3.3	1.8	1.4	11.0	1.4	2.0	6.1	3.9	3.6	4.7	3.4	1.9	2.7	6.5	2.0	6.0	4.3	2.6	10.5	2.7	2.0	8.1	4.2	3.3	2.1	5.1	4.5	2.6	4.2	3.1	2.5	1.6	4.8	2.8	12.2	0.9	7.7	0.1	3.7	2.9	2.1	2.9	1.3	1.7	1.9	1.4	1.9	1.6	2.3	1.0	17.9	16.8	5.3	3.5	2.1	2.5	5.1	7.6	2.7	4.5	19.2	0.0	1.8	3.3	2.0	0.7	6.5	0.3	70.0	2.9	11.5	7.6	2.4	26.5	1.9	32.5	1.6	8.1	78.5	15.6	0.0	2.6	3.1	8.5	1.0	2.3	11.1	3.8	0.0	3.9	0.8	2.2	19.4	20.8	3.3	6.4	0.9	2.5	8.7	1.4	1.1
FAM178B	LOC51252	ENSG00000168754	"Family with sequence similarity 178 member B"	Q8IXR5	2	96875882-96986592	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2;lymphoid tissue: 13.3;testis: 29.5"	"Cell type enhanced"	"Detected in some"	17	"Extravillous trophoblasts: 6.9;Late spermatids: 5.1;Spermatogonia: 19.4"	"Cancer enriched"	"Detected in many"	5	"melanoma: 8.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2;naive CD4 T-cell: 2.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"K-562: 17.5;OE19: 4.8;RH-30: 4.8;RPMI-8226: 19.1;WM-115: 19.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042516, HPA062110"	Uncertain		Uncertain	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles"	"Golgi apparatus"	"HPA042516: AB_10806241, HPA062110: "	"unprognostic (2.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.02e-4)"	"unprognostic (4.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.82e-11)"	"unprognostic (6.93e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.63e-3)"	"unprognostic (1.08e-1)"	0.8	0.0	2.4	0.6	3.8	18.2	0.6	1.0	1.5	0.6	1.0	0.6	0.6	0.1	0.7	6.8	0.6	1.5	0.6	0.6	3.4	1.9	0.6	0.6	0.6	0.6	5.3	0.6	0.6	0.6	0.0	0.6	1.1	0.6	0.6	0.2	1.0	0.6	1.0	0.6	1.2	0.6	0.6	8.5	13.3	0.0	29.5	0.6	0.6	0.6	0.6	0.6	1.0	0.6	0.0	0.8	0.0	0.0	0.1	2.6	0.6	4.2	0.0	0.0	1.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.4	1.7	0.0	0.0	0.1	4.8	0.0	0.0	4.8	19.1	0.0	0.0	0.6	0.0	0.0	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	19.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	1.7	0.0	0.1	0.0	0.8	0.0	0.6	2.4	3.8	1.0	1.5	3.4	1.9	5.3	0.6	0.6	0.6	0.0	0.0	0.8	0.6	0.7	0.1	0.3	0.0	0.0	0.0	0.0	2.0	2.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	6.9	1.4	0.2	0.0	0.0	1.1	1.6	0.0	0.6	0.0	5.1	0.9	0.3	3.3	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	1.7	19.4	1.5	2.1	0.0	0.0	0.1
FASTK	FAST	ENSG00000164896	"Fas activated serine/threonine kinase"	Q14296	7	151076593-151080866	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031621, CAB032539"	Approved		Supported	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"CAB032539: AB_2101115, HPA031621: AB_10611966"	"unprognostic (7.67e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.66e-2)"	"prognostic favorable (3.99e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.17e-2)"	13.8	16.8	18.8	15.7	19.0	6.4	10.2	19.0	26.4	18.0	20.6	13.4	20.3	21.2	12.4	14.6	20.3	16.7	16.8	35.7	17.6	12.9	17.7	25.6	9.5	10.4	12.0	15.0	14.4	20.7	20.2	21.8	18.5	12.0	16.8	10.6	14.0	21.7	17.9	89.5	14.4	25.8	11.3	9.2	14.9	14.8	10.6	10.9	11.2	16.8	28.1	16.9	17.4	11.8	15.4	26.0	19.7	22.3	13.1	19.0	14.5	15.9	18.6	5.9	14.2	22.1	10.0	9.9	12.8	17.4	10.9	13.1	12.8	13.7	3.8	17.5	17.3	20.1	10.3	5.7	15.3	2.9	10.9	10.2	4.6	4.6	10.8	28.1	3.2	10.5	13.0	22.5	12.6	9.3	8.9	12.8	9.5	6.8	8.0	12.6	31.9	7.8	9.2	9.9	19.8	21.8	5.2	7.1	11.8	14.8	10.9	7.1	7.4	16.9	26.2	17.0	5.3	14.1	12.7	10.4	13.9	3.0	13.0	11.3	21.4	13.0	2.4	27.7	7.2	15.9	10.5	22.3	19.7	16.4	21.7	17.1	13.7	17.3	16.9	19.4	15.4	19.0	16.3	4.8	13.1	20.8	26.0	18.7	14.5	18.8	19.0	19.0	26.4	17.6	12.9	12.0	15.0	12.0	10.9	0.0	6.5	32.8	35.2	21.9	39.2	16.5	28.1	2.7	12.5	24.4	23.6	42.5	72.9	43.5	7.1	22.2	63.6	0.0	41.8	23.0	34.8	27.1	39.1	31.6	38.4	35.0	43.1	22.7	26.6	11.6	33.6	25.5	89.4	34.3	42.5	51.0	35.5	39.6	32.2	50.2	48.9	12.9	27.8	47.1	68.2	22.1	50.6	38.4	50.8	26.7
HPD	"4-HPPD, 4HPPD, GLOD3, PPD"	ENSG00000158104	"4-hydroxyphenylpyruvate dioxygenase"	P32754	12	121839527-121863596	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 267.5"	"Group enriched"	"Detected in some"	9	"Hepatocytes: 1077.2;Proximal tubular cells: 1892.6"	"Cancer enriched"	"Detected in many"	100	"liver cancer: 540.9"	"Region enriched"	"Detected in single"	29	"pons and medulla: 13.7"	"Group enriched"	"Detected in many"	4	"eosinophil: 9.8;neutrophil: 4.8;plasmacytoid DC: 5.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.0;granulocytes: 9.8"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 107.2"	"Region enriched"	"Detected in single"	8	"amygdala: 0.4"	"Not detected"	"Not detected"			"HPA038321, HPA038322"	Enhanced		Uncertain	"Nuclear speckles"		NA	NA		23000000	"Nuclear speckles"		"HPA038321: AB_2675957, HPA038322: AB_10670778"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.14e-3)"	"unprognostic (9.72e-3)"	"unprognostic (8.61e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.34e-1)"	0.1	0.5	0.0	0.1	0.1	0.0	0.4	0.1	0.3	0.2	0.1	2.1	0.3	0.0	0.3	0.4	0.1	0.7	0.2	0.3	0.4	0.0	51.3	267.5	0.2	0.4	0.1	0.0	0.7	0.7	0.0	0.1	0.0	13.7	0.5	0.0	3.8	0.0	0.8	0.2	0.0	0.1	0.4	0.2	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.6	0.2	0.1	5.0	9.8	1.4	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	107.2	2.5	0.3	3.5	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.1	2.1	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	1.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.8	9.8	0.0	1.0	0.1	0.1	0.1	0.1	1.3	0.1	0.3	0.2	4.8	0.0	1.4	5.0	0.0	0.3	0.0	0.1	0.1	0.3	0.4	0.0	0.1	0.0	13.7	0.1	0.0	0.0	18.3	0.0	0.0	0.0	0.3	48.4	0.0	0.0	87.2	0.0	0.6	164.2	0.3	33.1	0.0	0.0	0.0	14.8	0.2	0.0	0.0	0.0	1077.2	0.3	0.0	0.0	33.2	23.4	97.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.9	1892.6	0.0	0.0	0.0	1.7	1.1	0.0	0.9	0.0	0.0	0.0
MAP3K7	"MEKK7, TAK1"	ENSG00000135341	"Mitogen-activated protein kinase kinase kinase 7"	O43318	6	90513573-90587045	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007633, HPA075335"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nuclear speckles, Plasma membrane"	"HPA007633: AB_1079359, HPA075335: "	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.17e-1)"	15.5	17.6	19.6	17.3	26.3	10.3	21.6	27.5	27.3	21.1	16.4	15.7	15.8	12.5	23.1	23.6	15.2	15.5	17.6	22.2	20.5	17.5	15.9	15.5	20.0	22.2	22.9	16.4	25.0	13.5	25.8	25.6	23.6	20.7	21.2	15.3	12.4	17.0	23.3	24.3	18.7	14.7	19.4	23.0	23.3	14.7	13.8	21.7	28.2	20.3	10.8	21.9	17.2	18.9	14.2	15.9	19.4	17.7	18.2	22.1	13.6	7.9	7.0	20.5	17.6	15.0	20.1	14.5	16.0	18.5	14.4	18.2	9.0	7.6	17.7	10.2	17.2	12.8	8.5	12.9	12.4	24.6	9.0	13.7	15.8	9.7	11.9	15.8	17.5	12.2	16.6	15.3	14.0	17.2	16.6	13.5	15.6	31.5	14.5	20.6	9.7	8.1	14.8	16.8	12.4	8.9	14.0	36.9	8.6	12.1	8.9	10.4	14.8	11.1	7.7	12.0	16.8	7.7	31.1	12.9	11.7	7.4	10.7	14.8	12.9	11.5	7.7	18.0	19.2	17.2	15.5	12.7	19.4	15.1	17.4	16.8	14.2	14.5	14.4	15.9	10.5	16.5	16.0	12.5	18.2	17.7	9.8	22.1	13.6	19.6	26.3	27.5	27.3	20.5	17.5	22.9	16.4	20.7	21.7	14.9	24.0	20.7	17.4	32.3	22.8	28.8	12.7	16.0	10.3	15.7	25.5	27.6	6.6	16.6	2.6	20.3	9.3	0.0	18.3	26.6	23.5	24.4	12.8	17.9	21.1	27.0	11.6	30.7	26.3	2.2	24.7	25.3	20.3	27.9	15.6	18.9	15.5	7.0	38.5	13.1	21.1	19.4	19.1	24.6	24.0	32.5	40.5	25.5	15.1	23.0
MOCS2	MOCO1	ENSG00000164172	"Molybdenum cofactor synthesis 2"	"O96007, O96033"	5	53095679-53110063	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Distal tubular cells: 485.7;Proximal tubular cells: 194.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037679, HPA037680"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nuclear speckles"	"HPA037679: AB_2675604, HPA037680: AB_10673635"	"unprognostic (3.27e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.68e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.86e-2)"	18.1	34.6	41.5	9.8	38.0	4.0	19.6	21.7	41.8	16.0	17.1	20.7	10.4	17.6	14.8	28.2	17.0	12.9	15.9	39.9	36.7	32.1	49.7	52.0	13.1	11.4	30.0	22.4	21.2	18.4	30.4	23.3	16.2	28.7	18.6	14.9	17.2	21.2	20.8	38.3	8.9	17.6	16.1	27.1	10.7	16.6	11.0	20.0	8.2	31.5	19.4	11.2	16.9	15.4	16.9	12.5	6.3	10.9	17.3	25.8	12.9	20.2	16.6	12.0	28.7	24.6	22.7	15.2	24.9	26.2	22.2	26.4	22.6	15.2	20.7	37.5	19.6	34.4	12.3	24.0	25.5	35.0	5.2	23.4	15.9	16.3	20.4	25.3	17.2	12.0	18.1	12.8	25.2	22.5	22.0	23.8	26.7	15.4	11.3	37.0	30.0	18.5	9.8	10.6	8.7	34.6	9.4	25.8	18.8	38.4	15.4	8.9	10.3	18.1	14.8	18.6	15.9	28.6	4.4	15.2	21.3	22.1	18.9	32.0	13.3	19.7	23.4	30.5	4.9	32.9	5.2	9.2	6.3	16.9	10.9	20.2	16.5	19.0	19.2	12.5	16.9	25.8	22.2	1.7	17.3	9.8	11.4	18.3	12.9	41.5	38.0	21.7	41.8	36.7	32.1	30.0	22.4	28.7	20.0	50.6	20.6	25.2	32.7	11.8	27.0	111.0	66.2	36.1	19.4	66.3	25.5	82.4	485.7	34.6	5.6	32.8	17.8	0.0	38.2	28.9	48.8	44.5	9.3	99.9	36.5	6.4	25.3	19.0	25.0	10.1	46.9	27.4	21.9	7.2	17.9	36.8	23.4	19.3	64.7	194.9	18.1	32.3	50.3	40.7	54.7	13.7	27.0	26.1	22.9	30.2
NDUFB1	"CI-MNLL, MNLL"	ENSG00000183648	"NADH:ubiquinone oxidoreductase subunit B1"	O75438	14	92116122-92121917	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 161.6"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 2033.2;Hepatocytes: 1436.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA063737	Supported		Supported	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"HPA063737: AB_2685109"	"unprognostic (1.12e-2)"	"unprognostic (1.31e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.74e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.55e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.15e-2)"	"prognostic favorable (1.31e-5)"	"unprognostic (7.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.05e-3)"	38.3	48.3	47.8	22.4	43.1	30.2	22.1	30.9	53.6	12.4	39.7	13.4	28.1	36.4	14.8	39.2	23.2	15.9	20.0	142.2	38.4	35.7	51.2	64.6	28.1	24.9	40.6	36.0	16.5	48.5	9.9	30.6	13.2	41.8	19.3	26.9	22.9	54.1	35.9	161.6	12.6	32.9	25.9	31.3	19.3	29.4	10.0	26.4	11.9	21.6	48.9	21.3	17.1	16.3	61.7	98.6	116.1	93.9	45.1	70.1	95.0	27.1	55.1	44.7	28.8	29.3	21.9	20.5	33.5	18.9	19.9	18.4	33.2	46.3	24.5	31.2	18.7	29.1	34.0	25.6	27.2	18.0	38.6	58.5	47.5	86.5	39.5	23.3	37.5	27.2	27.0	16.5	20.8	18.4	47.1	17.7	47.1	25.8	50.5	27.2	102.8	37.0	33.6	22.6	103.1	67.5	33.1	42.5	36.4	49.6	67.3	29.9	21.7	65.6	40.0	42.6	39.3	59.8	58.6	39.5	12.7	24.1	25.3	22.3	40.0	62.3	54.5	38.2	27.8	26.2	58.1	93.9	67.8	43.7	63.5	50.2	61.7	64.7	49.8	82.6	52.0	65.4	60.4	116.1	45.1	58.1	98.6	70.1	95.0	47.8	43.1	30.9	53.6	38.4	35.7	40.6	36.0	41.8	26.4	154.9	246.4	237.3	88.1	114.4	72.8	2033.2	565.6	282.4	178.6	369.9	37.3	225.4	988.2	197.4	98.7	145.0	655.0	280.4	371.9	86.0	164.5	117.3	207.1	1436.2	359.0	52.4	305.2	426.6	707.7	29.0	243.1	282.3	315.5	296.6	433.5	108.9	268.5	512.0	226.7	864.5	130.9	219.9	185.4	133.6	144.5	153.9	172.1	204.2	467.2	90.1
NLRP12	"CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2"	ENSG00000142405	"NLR family pyrin domain containing 12"	P59046	19	53793603-53824394	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 22.8;bone marrow: 11.0;lung: 6.5;lymphoid tissue: 13.5"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 9.0;Club cells: 6.8;granulocytes: 7.0;Kupffer cells: 12.3;Macrophages: 6.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 2.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 22.8;neutrophil: 15.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 22.8;monocytes: 8.7"	"Group enriched"	"Detected in some"	4	"HMC-1: 7.7;THP-1: 6.7;U-87 MG: 7.3;U-937: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042099, HPA042981"	Approved		Uncertain	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA042099: , HPA042981: AB_10795712"	"unprognostic (6.92e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.66e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.81e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.48e-1)"	1.9	0.3	0.2	4.2	0.6	11.0	0.4	0.2	0.2	0.9	0.3	0.1	0.9	0.3	0.7	0.7	0.6	1.0	0.5	3.3	0.2	0.2	0.5	0.5	6.5	13.5	0.6	0.3	1.0	0.3	0.1	0.2	1.1	0.8	0.3	0.1	0.5	1.7	0.0	0.2	0.2	0.3	1.4	0.5	10.2	0.4	1.0	0.6	0.3	0.3	0.4	0.2	1.1	1.4	0.0	3.6	22.8	8.7	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.6	7.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	6.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	7.3	6.1	0.0	22.8	8.7	11.0	0.0	2.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	15.0	0.0	1.5	0.0	0.0	2.1	0.2	0.6	0.2	0.2	0.2	0.2	0.6	0.3	0.8	0.6	6.0	9.0	0.0	0.7	0.3	0.8	0.4	0.0	4.0	6.8	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.4	0.7	7.0	0.0	2.4	0.0	0.0	0.0	12.3	0.0	0.3	6.1	1.7	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.6
NR5A2	"B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1"	ENSG00000116833	"Nuclear receptor subfamily 5 group A member 2"	O00482	1	200027602-200177424	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"intestine: 38.7;liver: 36.1;pancreas: 100.4"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 35.9;Exocrine glandular cells: 46.6;Hepatocytes: 34.2;Ito cells: 46.1;Pancreatic endocrine cells: 31.2;Undifferentiated cells: 29.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"A549: 19.7;HAP1: 12.0;HMC-1: 5.2;HUVEC TERT2: 16.5"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.5"					"HPA005455, HPA017067"	Approved		Uncertain	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA005455: AB_1078140, HPA017067: AB_1844767"	"unprognostic (7.47e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-7)"	"unprognostic (5.48e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.37e-1)"	2.9	0.2	0.2	4.5	0.3	0.0	2.6	0.2	0.2	2.3	23.8	0.2	0.6	8.1	3.5	1.3	0.7	1.3	5.7	0.5	0.2	0.4	0.4	36.1	1.6	0.7	0.3	0.3	1.0	100.4	0.0	0.3	0.3	0.3	1.1	6.3	0.3	0.5	1.3	1.0	0.7	38.7	1.8	0.4	0.3	0.6	0.6	0.2	0.2	0.8	0.3	0.4	0.8	1.1	1.3	1.4	5.5	1.2	1.5	1.1	0.3	0.0	19.7	0.0	0.1	0.0	0.2	0.5	0.0	0.3	0.0	0.0	4.4	0.1	0.0	0.0	0.0	0.6	0.5	12.0	0.0	0.0	2.5	0.8	0.0	0.2	2.0	0.4	0.0	5.2	0.1	0.0	0.0	0.1	0.0	16.5	0.1	0.0	0.3	0.0	0.5	0.0	0.3	0.8	0.0	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.6	3.8	0.3	0.1	0.8	0.2	0.1	0.1	2.8	1.8	2.0	0.3	0.1	0.1	5.5	1.2	1.1	0.6	0.7	0.7	0.7	1.0	0.8	0.4	1.3	1.1	1.0	4.2	1.5	0.5	1.4	0.9	0.3	0.2	0.3	0.2	0.2	0.2	0.4	0.3	0.3	0.3	0.2	0.0	1.7	0.0	0.1	1.6	0.1	6.2	22.9	1.4	0.0	0.0	0.0	0.0	0.0	25.4	0.2	16.3	35.9	0.0	46.6	0.0	0.6	0.2	12.7	34.2	0.1	0.0	4.7	46.1	6.5	0.0	0.6	0.0	0.0	5.4	9.8	0.0	31.2	24.6	0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.3	0.0	0.0	29.8	0.2
NUP43	"bA350J20.1, FLJ13287"	ENSG00000120253	"Nucleoporin 43"	Q8NFH3	6	149724315-149749665	"Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027126, HPA027291, HPA028500"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287"	"prognostic unfavorable (2.08e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (7.13e-7)"	"unprognostic (5.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	16.9	14.2	12.7	15.2	13.8	7.6	19.6	15.6	13.5	20.1	13.1	17.9	18.3	12.4	18.4	11.5	17.4	13.1	9.1	14.7	10.9	10.0	15.7	13.7	12.6	20.3	15.2	9.2	15.7	22.6	14.1	13.2	18.8	12.9	16.6	14.1	17.7	14.2	14.2	20.0	18.7	16.6	16.2	12.1	22.7	14.4	13.8	16.4	28.6	18.9	12.1	24.2	18.4	14.2	10.6	8.1	5.1	8.6	6.1	9.7	3.3	9.0	15.8	13.9	21.8	8.9	11.2	21.8	15.7	9.0	15.4	19.5	22.6	8.5	26.1	16.8	8.6	14.4	14.5	23.8	13.8	26.2	12.2	16.7	29.9	16.8	21.0	6.1	30.6	19.5	6.8	7.3	22.4	14.3	5.8	12.1	15.1	30.5	14.6	12.8	9.7	22.0	12.7	12.2	10.3	9.4	21.6	19.2	8.7	10.1	12.6	5.7	9.6	18.7	11.9	6.1	12.0	12.7	13.0	9.4	12.6	13.7	17.9	23.9	9.0	18.3	28.0	11.2	21.3	17.6	4.4	8.3	5.1	6.3	8.6	6.6	7.3	7.4	6.2	4.2	10.6	7.8	9.7	3.3	6.1	7.2	8.1	7.9	3.3	12.7	13.8	15.6	13.5	10.9	10.0	15.2	9.2	12.9	16.4	3.0	5.6	6.2	4.5	7.0	11.7	12.6	10.2	2.7	4.5	3.5	5.9	9.5	3.3	7.6	27.2	5.3	3.4	0.0	6.7	10.5	4.7	5.3	0.0	3.2	6.7	6.4	9.8	6.2	10.3	58.0	9.5	6.0	8.5	10.0	5.8	11.1	5.5	0.0	9.9	3.8	9.5	12.9	8.2	4.9	10.0	7.4	5.5	6.9	7.6	5.6
OTX1		ENSG00000115507	"Orthodenticle homeobox 1"	P32242	2	63050057-63057836	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.3;retina: 18.9;salivary gland: 19.6;skin 1: 14.3"	"Cell type enhanced"	"Detected in some"	21	"Basal keratinocytes: 1.4;Ciliated cells: 6.7;Club cells: 2.3;Suprabasal keratinocytes: 2.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	113	"neutrophil: 11.3"	"Lineage enriched"	"Detected in single"	113	"granulocytes: 11.3"	"Cell line enriched"	"Detected in many"	9	"THP-1: 34.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB012341, HPA052122"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"CAB012341: AB_2157155, HPA052122: AB_2681736"	"unprognostic (2.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.71e-1)"	"unprognostic (0.00e+0)"	"unprognostic (4.64e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.80e-4)"	"unprognostic (3.67e-3)"	0.5	0.4	8.2	0.4	4.3	0.4	1.1	0.2	7.2	0.4	0.4	5.8	0.0	0.6	0.4	0.4	1.4	0.5	0.5	0.4	9.0	1.4	0.4	0.5	0.8	0.4	2.0	3.4	0.6	0.6	0.4	0.1	0.4	0.1	2.3	0.4	18.9	19.6	0.4	0.4	14.3	0.4	0.4	0.1	0.6	1.0	0.9	4.4	0.0	0.4	4.4	5.6	0.6	0.2	0.0	0.0	11.3	0.0	0.0	0.0	0.0	1.5	0.8	2.8	1.7	0.0	0.1	3.9	0.0	0.2	0.2	0.2	2.8	1.5	0.1	0.5	0.0	0.7	2.0	1.8	1.2	0.3	0.7	1.6	1.8	1.4	3.2	0.0	1.2	1.3	0.0	0.5	0.0	0.5	0.5	0.0	1.7	1.5	0.0	0.1	1.3	1.6	2.9	0.0	1.4	1.0	1.5	2.4	0.4	0.7	0.5	0.3	0.4	1.1	0.1	0.9	0.0	0.6	34.7	0.1	0.6	1.1	0.0	0.6	1.0	0.7	2.6	0.2	1.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	8.2	4.3	0.2	7.2	9.0	1.4	2.0	3.4	0.1	4.4	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.0	6.7	2.3	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	2.3	0.1	0.0	0.0	0.0
PRDM7	ZNF910	ENSG00000126856	"PR/SET domain 7"	Q9NQW5	16	90056566-90092072	"Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	27	"testis: 4.8"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 1.4;Cardiomyocytes: 5.0;Ciliated cells: 2.7"	"Cancer enriched"	"Detected in single"	30	"melanoma: 3.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"REH: 9.1;SK-MEL-30: 6.7"									HPA059944	Approved		Uncertain	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA059944: AB_2684174"	"unprognostic (3.98e-1)"	"unprognostic (8.89e-2)"		"unprognostic (8.02e-3)"	"unprognostic (8.26e-2)"		"unprognostic (9.01e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.46e-1)"		"unprognostic (5.73e-1)"	"unprognostic (5.52e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.03e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8			0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0											0.0	1.4	0.0	0.0	0.0	0.0	5.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0
RBP7	CRBPIV	ENSG00000162444	"Retinol binding protein 7"	Q96R05	1	9997206-10016020	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 68.1;breast: 210.2"	"Group enriched"	"Detected in many"	5	"Endothelial cells: 121.4;Kupffer cells: 402.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 54.1;intermediate monocyte: 23.4;neutrophil: 60.6"	"Group enriched"	"Detected in many"	30	"granulocytes: 60.6;monocytes: 54.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.5;SK-MEL-30: 7.1;T-47d: 26.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA034749	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA034749: AB_10602084"	"unprognostic (1.93e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (9.59e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.90e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	68.1	3.7	3.8	3.0	11.4	7.5	210.2	2.1	5.5	4.3	10.9	8.7	2.7	0.5	6.4	4.5	7.2	2.4	14.7	29.7	5.3	2.8	7.6	2.5	2.5	4.5	7.6	3.0	2.6	3.7	14.7	3.5	4.4	6.2	4.7	1.2	3.5	4.8	2.7	5.9	6.6	2.0	4.4	8.9	21.5	3.0	2.6	5.2	1.2	11.3	1.8	1.4	4.5	17.5	0.0	1.8	60.6	54.1	0.0	0.1	15.0	0.0	0.6	0.2	0.0	0.0	0.4	0.0	0.0	0.0	2.0	0.8	1.8	2.4	0.0	10.5	1.0	0.0	0.0	0.0	0.8	3.4	0.0	2.5	0.0	0.1	0.9	1.2	0.0	0.0	0.0	1.6	1.6	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	4.4	0.0	0.0	0.0	0.5	0.0	0.1	0.4	1.9	0.1	7.1	2.9	26.8	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	54.1	0.4	0.0	23.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	60.6	0.0	11.1	0.3	0.1	15.0	3.8	11.4	2.1	5.5	5.3	2.8	7.6	3.0	6.2	5.2	0.0	2.2	11.2	7.8	18.3	0.0	17.6	10.2	1.4	1.2	1.8	0.0	4.5	19.9	1.3	2.6	121.4	0.0	0.0	2.3	2.2	8.2	19.2	3.5	1.3	54.6	0.0	0.0	49.7	402.1	4.7	5.8	23.1	20.3	0.0	0.0	1.3	3.7	0.0	0.7	0.7	1.1	0.0	5.3	1.2	1.5	15.4	5.1	1.3	0.4	4.3
S1PR2	"AGR16, DFNB68, EDG5, Gpcr13, H218"	ENSG00000267534	"Sphingosine-1-phosphate receptor 2"	O95136	19	10221433-10231331	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 75.1;Early spermatids: 83.7;Late spermatids: 119.0;Syncytiotrophoblasts: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 23.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 23.7;T-cells: 7.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 14.6;Daudi: 25.8;U-266/70: 19.3;U-698: 27.9;WM-115: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014255, HPA014307"	Approved		Uncertain	"Nuclear speckles,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Nuclear speckles"	"HPA014255: , HPA014307: AB_1847989"	"unprognostic (5.38e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.05e-3)"	"unprognostic (8.50e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.91e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.09e-2)"	17.1	2.3	1.4	13.7	1.3	0.9	7.2	0.9	1.5	13.3	4.1	1.7	3.9	1.8	8.3	9.2	6.4	7.9	6.5	6.1	1.3	1.5	2.4	9.5	11.2	10.6	1.3	0.0	12.9	2.6	3.9	2.2	31.3	1.7	9.8	2.5	3.2	9.4	5.7	3.4	4.0	3.9	8.7	1.7	2.2	4.2	21.8	1.0	2.0	3.3	6.3	15.6	8.0	12.0	0.3	1.6	23.7	1.9	2.1	7.4	1.2	1.4	0.2	1.7	3.4	9.4	11.5	14.6	2.1	4.4	1.0	2.0	0.9	0.8	25.8	2.5	4.0	1.1	0.8	0.6	1.0	0.7	2.6	1.3	0.6	0.6	0.6	3.1	0.7	0.6	6.3	0.5	1.9	0.6	2.7	0.1	1.3	0.6	5.6	0.6	1.2	0.3	1.2	1.7	0.4	0.8	1.8	0.7	0.9	0.8	1.2	1.2	2.3	1.2	0.7	1.8	1.4	0.6	0.6	0.2	3.5	1.1	7.9	0.6	19.3	9.1	27.9	1.3	1.3	19.1	23.7	1.9	0.4	4.9	1.5	5.9	0.2	6.2	4.6	1.6	0.3	2.6	2.6	0.5	2.1	0.6	0.2	7.4	1.2	1.4	1.3	0.9	1.3	1.3	1.5	1.3	0.0	1.7	1.0	0.0	1.4	0.0	3.5	0.0	0.6	0.4	0.0	0.0	1.2	1.8	2.0	75.1	0.0	3.1	83.7	1.5	0.0	0.0	2.7	13.9	15.8	4.2	0.0	5.9	12.5	0.0	2.4	4.9	0.6	119.0	20.4	4.8	0.0	4.6	0.1	7.1	2.3	0.0	12.4	0.5	0.4	12.9	2.0	1.2	1.1	0.0	57.2	1.5	0.0	2.6
SERPINB13	"headpin, HUR7, hurpin, PI13"	ENSG00000197641	"Serpin family B member 13"	Q9UIV8	18	63586989-63604639	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"cervix, uterine: 37.7;esophagus: 70.8;lymphoid tissue: 54.2;tongue: 107.2;vagina: 34.1"	"Group enriched"	"Detected in some"	11	"Ciliated cells: 8.1;Club cells: 29.6;Urothelial cells: 8.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 45.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	132	"HaCaT: 65.6;hTCEpi: 25.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052630, HPA057129"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA		59000	"Nuclear speckles, Cytosol"		"HPA052630: AB_2681891, HPA057129: AB_2683347"		"unprognostic (3.49e-2)"		"unprognostic (3.73e-1)"		"unprognostic (1.11e-1)"		"unprognostic (7.27e-2)"	"unprognostic (2.28e-1)"			"unprognostic (4.29e-2)"		"unprognostic (2.81e-1)"			"unprognostic (6.04e-3)"	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.1	37.7	0.1	0.0	0.0	0.1	3.1	0.1	70.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	10.9	0.1	0.2	5.7	0.1	0.1	0.0	0.1	0.1	0.1	0.0	1.0	0.1	107.2	54.2	1.5	34.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.0	0.0	0.0	8.1	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	8.5
SHANK2	"CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3"	ENSG00000162105	"SH3 and multiple ankyrin repeat domains 2"	Q9UPX8	11	70467856-71252577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 38.7;Horizontal cells: 128.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.9;MCF7: 9.7;RT4: 15.6;T-47d: 12.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008174, HPA017220"	Approved		Uncertain	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	NA			Nucleoplasm	"Nuclear speckles, Vesicles"	"HPA008174: AB_1856822, HPA017220: "	"unprognostic (3.08e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.23e-5)"	"unprognostic (1.24e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (1.94e-6)"	"unprognostic (3.46e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.03e-2)"	"unprognostic (4.80e-2)"	2.1	1.7	16.8	0.8	22.6	0.0	7.3	6.1	24.1	2.8	3.1	2.3	1.9	2.4	1.8	3.1	5.1	7.9	1.1	0.2	12.2	8.1	7.0	4.7	5.5	0.3	3.6	12.9	0.2	11.3	0.0	7.3	2.7	8.7	4.6	2.8	1.4	12.7	3.3	0.1	1.2	2.0	0.6	1.5	1.5	4.7	1.2	3.7	0.0	8.5	0.0	0.5	2.3	0.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	7.8	4.3	0.0	0.5	0.7	3.1	0.6	0.3	0.0	0.0	8.2	2.9	5.1	1.5	0.0	0.2	0.8	0.0	2.9	0.0	0.0	0.2	0.0	0.0	8.5	0.0	0.0	1.7	0.2	1.5	0.0	0.0	1.1	0.0	0.1	0.0	16.9	1.6	9.7	0.0	0.0	3.3	7.4	0.3	0.0	7.7	7.6	3.9	15.6	2.5	1.0	0.0	6.2	0.0	3.6	12.0	0.0	0.0	0.1	1.2	0.3	0.0	0.1	0.6	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.8	22.6	6.1	24.1	12.2	8.1	3.6	12.9	8.7	3.7	38.7	14.2	0.0	2.7	0.0	16.0	2.4	10.2	20.1	5.7	7.0	0.0	9.5	3.3	7.0	1.4	1.0	0.9	0.0	1.9	2.4	0.6	8.4	2.3	19.0	1.0	128.7	0.0	0.0	0.0	1.6	0.0	0.5	5.0	0.0	8.2	5.0	7.6	3.5	0.7	8.7	0.9	0.0	1.4	0.6	0.7	0.5	12.2	0.0	5.2	3.8
SLC25A12	Aralar	ENSG00000115840	"Solute carrier family 25 member 12"	O75746	2	171784370-171999859	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.7"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035333, HPA035334"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA035333: AB_10603028, HPA035334: AB_2674577"	"unprognostic (3.24e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (2.65e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.21e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.91e-8)"	"unprognostic (8.64e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	6.4	6.7	8.8	6.2	18.2	2.9	9.2	17.9	25.0	10.6	12.2	5.7	5.2	4.2	10.4	7.1	11.5	6.9	5.9	42.4	9.9	13.4	10.7	1.9	5.2	6.5	10.4	12.4	10.0	3.5	16.4	14.7	4.7	15.2	10.6	10.0	11.0	21.7	14.8	84.7	7.6	5.7	14.3	7.1	5.6	9.0	4.3	6.2	5.8	10.1	23.8	8.4	10.0	6.7	6.4	3.6	5.1	4.6	6.6	8.1	2.9	7.2	5.3	5.6	13.0	16.7	18.9	0.1	9.2	15.7	12.6	12.1	2.8	6.8	22.9	6.1	10.8	9.8	9.1	11.8	11.6	15.8	14.0	11.1	10.0	7.7	6.7	6.4	20.0	10.0	16.5	11.5	14.6	4.2	6.8	13.0	9.1	6.9	10.5	8.0	4.4	14.1	8.4	4.5	6.1	7.5	14.7	8.1	11.9	13.2	6.3	7.9	2.5	5.8	13.7	7.3	3.8	5.0	5.9	8.9	10.5	4.6	11.6	6.3	14.2	9.1	23.2	14.5	10.6	7.1	5.1	3.0	1.6	6.5	3.9	7.3	6.4	4.5	6.8	3.6	3.9	6.3	8.1	0.2	6.6	4.6	0.6	4.5	2.9	8.8	18.2	17.9	25.0	9.9	13.4	10.4	12.4	15.2	6.2	0.0	6.0	1.5	11.2	6.2	25.4	94.4	0.0	13.4	22.7	17.4	23.6	6.0	16.6	1.5	2.5	7.0	5.6	23.3	2.9	1.2	7.0	4.3	10.4	0.2	4.0	35.0	13.8	8.6	7.3	1.7	11.5	5.4	15.1	6.4	7.0	18.3	1.3	3.5	23.0	10.9	22.1	12.9	11.8	3.2	9.0	6.8	1.0	8.7	7.4	4.6
SLC28A1	CNT1	ENSG00000156222	"Solute carrier family 28 member 1"	O00337	15	84884654-84945796	"Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"intestine: 32.7;kidney: 35.6;liver: 43.8"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 34.1;Hofbauer cells: 40.6;Proximal tubular cells: 88.5"	"Group enriched"	"Detected in some"	63	"liver cancer: 10.9;renal cancer: 33.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 2.0;Karpas-707: 1.1;RPMI-8226: 1.6;SK-BR-3: 1.8;SuSa: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019551, HPA056247"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nuclear speckles, Cytosol"	"HPA019551: AB_2670187, HPA056247: "	"unprognostic (3.81e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.42e-2)"	"unprognostic (7.72e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	5.0	0.1	0.1	17.3	0.1	1.5	0.1	0.1	0.1	0.5	0.1	0.1	35.6	43.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	32.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.5	0.3	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.1	0.4	0.1	1.8	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	7.6	1.4	0.0	7.0	0.0	0.4	10.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	34.1	40.6	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	88.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"kidney: 94.5"	"Cell type enriched"	"Detected in some"	16	"Proximal tubular cells: 128.7"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Group enriched"	"Detected in some"	12	"HEL: 6.7;U-937: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA			"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	7.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
TAP2	"ABCB3, D6S217E, PSF2, RING11"	ENSG00000204267	"Transporter 2, ATP binding cassette subfamily B member"	Q03519	6	32821833-32838780	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"monocytes: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 28.6;U-251 MG: 28.3"									HPA001312	Approved		Supported	"Nuclear speckles,Endoplasmic reticulum"		NA	NA		14000	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA001312: AB_1080206"	"unprognostic (2.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (5.22e-8)"	"unprognostic (5.32e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.71e-2)"	12.8	8.4	6.5	22.5	6.9	14.7	9.5	6.3	7.3	8.8	15.0	7.6	3.3	15.3	9.6	5.9	17.4	7.9	11.5	7.7	5.2	6.0	10.8	19.0	18.0	14.0	7.1	6.3	9.7	6.1	2.6	5.8	5.7	7.9	8.2	11.9	7.9	12.1	5.2	5.8	9.6	28.0	7.0	6.1	24.9	7.7	3.3	6.9	25.9	14.7	7.1	20.1	23.6	10.7	0.9	2.8	4.9	5.4	2.9	4.1	1.9	7.9	0.0	0.0	2.3	2.2	3.1	0.0	0.5	1.6	6.2	8.5	2.1	16.3	15.5	3.1	4.0	11.2	8.3	7.1	28.6	2.5	10.5	0.9	1.8	6.1	0.7	1.0	0.0	12.3	0.3	0.4	8.4	13.1	0.0	4.0	0.0	8.6	5.2	0.0	0.6	2.0	1.0	0.3	0.6	4.0	8.4	0.0	5.9	5.2	0.1	0.1	0.0	7.7	16.4	1.6	0.3	0.8	0.0	2.3	8.8	2.0	2.3	28.3	8.1	13.4	14.5	8.1	10.9	1.6	1.7	2.0	1.8	4.1	5.4	2.0	0.9	1.2	2.7	2.0	0.6	1.0	0.6	4.9	2.9	4.1	2.8	1.9	1.9	6.5	6.9	6.3	7.3	5.2	6.0	7.1	6.3	7.9	6.9	0.0	6.9	28.3	12.0	0.0	4.5	2.4	2.5	2.7	6.8	14.0	2.0	1.2	1.7	33.7	0.0	28.7	19.3	0.0	28.6	35.6	4.1	11.3	4.7	5.8	22.4	17.5	3.5	16.0	12.3	0.0	5.2	14.5	0.0	92.8	18.4	18.9	27.4	13.9	5.6	4.7	4.8	0.0	7.5	0.4	1.2	0.0	1.4	24.5	10.3	14.8
TOR1B	"DQ1, MGC4386"	ENSG00000136816	"Torsin family 1 member B"	O14657	9	129803153-129811281	"Predicted intracellular proteins"		"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013403, HPA013697, CAB022709"	Approved		Uncertain	"Nuclear speckles,Cytosol"	"Intracellular and membrane"	NA	NA			"Nuclear speckles"	Cytosol	"CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196"	"unprognostic (2.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.69e-3)"	14.2	14.4	9.7	13.8	12.2	14.0	18.4	23.6	11.9	11.3	22.5	10.5	11.6	12.3	14.0	8.2	13.5	10.5	15.0	13.3	11.7	11.5	11.8	35.3	13.0	10.8	9.4	9.0	10.8	21.1	13.3	13.6	20.0	10.6	12.9	25.8	10.8	12.8	13.7	13.5	13.0	18.1	14.2	8.9	12.4	14.9	19.5	8.3	16.8	16.4	10.0	11.9	14.9	18.0	4.6	6.2	17.2	14.6	7.3	12.3	8.4	5.3	12.3	5.1	13.7	25.9	19.4	12.0	19.2	12.5	13.2	13.1	10.1	12.2	3.8	12.2	18.8	20.6	21.8	5.6	7.9	13.6	13.9	5.9	3.3	10.4	7.1	11.1	6.3	14.9	11.0	13.9	18.8	9.3	9.8	11.7	10.1	11.5	8.9	12.3	14.9	8.6	9.9	10.8	25.1	9.7	3.5	9.0	11.5	10.1	5.6	7.1	8.3	12.4	14.3	7.6	9.7	20.6	6.2	10.7	25.0	11.9	29.7	16.4	6.5	24.2	3.2	13.7	8.2	16.9	6.3	11.5	17.2	12.2	14.6	12.3	3.9	9.5	10.5	6.2	4.6	7.1	7.1	14.2	7.3	8.5	3.8	9.1	8.4	9.7	12.2	23.6	11.9	11.7	11.5	9.4	9.0	10.6	8.3	8.9	3.7	4.5	5.2	5.8	2.5	5.1	5.1	5.3	1.2	5.2	3.9	9.7	0.0	8.8	9.2	6.7	8.0	0.0	12.2	15.2	8.5	9.2	4.6	13.5	10.8	6.4	18.4	11.6	4.3	10.9	4.0	7.6	3.3	12.6	15.5	4.8	10.0	3.5	5.3	3.0	2.5	19.4	9.5	10.3	7.0	4.6	12.7	10.0	10.7	10.1
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149342-41154337	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 37.9;bone marrow: 10.5;heart muscle: 10.0;lymphoid tissue: 26.7"	"Cell type enriched"	"Detected in some"	11	"monocytes: 44.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 19.2"	"Lineage enriched"	"Detected in single"	31	"granulocytes: 19.2"	"Cell line enriched"	"Detected in single"	167	"HEL: 38.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		94000000	"Nuclear speckles, Cytosol"	"Golgi apparatus, Plasma membrane"	"HPA016700: AB_1858262, HPA017860: AB_1858261"	"unprognostic (6.70e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.53e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.41e-2)"	1.2	1.2	2.1	3.7	1.2	10.5	0.6	0.5	1.3	0.4	0.3	0.3	0.3	0.0	0.3	0.6	0.3	0.6	1.3	10.0	2.1	1.6	0.3	0.3	2.9	7.7	3.3	0.3	1.9	0.5	0.2	0.6	1.7	1.2	0.3	1.3	0.6	1.3	0.3	0.8	0.3	0.4	0.3	4.3	26.7	0.2	0.8	0.3	1.4	0.6	0.3	7.1	1.1	0.3	0.1	0.3	19.2	0.6	0.0	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	38.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.6	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	3.9	0.0	0.1	0.3	0.0	37.9	2.1	1.2	0.5	0.7	2.1	1.6	3.3	0.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	1.0	0.0	0.0	1.7	0.0	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ZMYND15	DKFZp434N127	ENSG00000141497	"Zinc finger MYND-type containing 15"	Q9H091	17	4740015-4746119	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.6"	"Group enriched"	"Detected in many"	6	"Early spermatids: 141.0;monocytes: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.1;non-classical monocyte: 1.5"	"Group enriched"	"Detected in many"	11	"granulocytes: 1.1;monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"A-431: 5.1;CAPAN-2: 4.8;HaCaT: 3.9;T-47d: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023286			Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA023286: AB_1859076"	"unprognostic (2.30e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.62e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.49e-1)"	"unprognostic (6.72e-3)"	"unprognostic (4.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	3.6	1.6	2.3	2.9	2.0	0.9	2.0	0.7	2.7	1.3	1.0	5.1	1.4	5.2	1.8	4.5	1.2	1.5	3.8	3.8	3.6	1.8	2.4	3.5	6.1	4.9	3.7	1.7	0.9	4.7	12.5	1.8	1.5	3.4	1.9	1.0	4.2	3.8	2.7	0.4	1.8	3.9	1.2	4.8	6.2	2.4	25.6	2.9	0.7	1.4	0.7	0.8	1.6	0.9	0.0	0.1	1.1	1.5	0.0	0.0	0.2	5.1	0.9	0.0	2.5	0.1	0.2	0.4	0.1	1.4	1.3	3.1	2.3	4.8	0.0	0.2	0.0	0.6	3.9	0.9	0.4	0.1	0.5	1.7	0.0	0.5	1.3	0.8	0.1	1.4	0.2	0.6	0.2	0.2	0.7	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.7	0.6	0.6	0.0	0.1	1.4	1.6	2.3	0.0	3.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	1.5	0.0	0.0	0.2	2.3	2.0	0.7	2.7	3.6	1.8	3.7	1.7	3.4	2.9	0.0	1.3	0.0	5.2	0.8	0.1	0.6	0.0	0.0	1.2	1.8	0.0	0.0	0.0	1.4	141.0	0.3	4.0	0.0	3.5	0.0	0.3	5.3	0.0	0.2	5.0	0.0	1.2	3.7	7.6	15.1	0.6	10.7	1.7	36.9	2.6	1.4	2.6	0.6	2.1	0.7	0.2	0.0	0.5	0.7	1.2	0.6	0.0	0.0	0.6	7.4
ZSCAN5A	"MGC4161, ZNF495, ZSCAN5"	ENSG00000131848	"Zinc finger and SCAN domain containing 5A"	Q9BUG6	19	56219670-56368383	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 29.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 101.0;Late spermatids: 64.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041263, HPA043123, HPA046836, HPA060667"	Uncertain		Uncertain	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: "	"unprognostic (1.72e-1)"	"unprognostic (3.19e-3)"	"unprognostic (8.22e-4)"	"unprognostic (1.65e-2)"	"unprognostic (2.05e-3)"	"unprognostic (6.99e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.67e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.70e-2)"	"unprognostic (6.15e-3)"	"unprognostic (3.99e-3)"	4.0	4.9	5.2	5.4	9.9	3.8	4.3	5.9	8.0	6.0	6.0	6.5	4.9	6.1	6.6	5.0	4.7	11.3	4.3	8.1	5.2	4.8	5.6	5.8	5.0	4.3	4.9	3.9	6.3	5.9	6.4	14.3	4.9	6.9	4.6	7.4	9.9	5.7	7.8	5.9	6.1	5.6	6.3	3.4	4.6	4.1	29.9	5.5	7.6	5.4	5.9	5.3	4.6	4.7	4.2	10.8	4.7	8.9	1.4	8.0	4.1	4.8	4.2	6.1	7.4	5.0	3.2	8.9	2.9	6.2	8.8	5.3	8.4	2.9	8.7	2.3	5.0	5.3	6.0	7.8	6.2	8.0	2.5	16.5	10.7	2.8	8.3	4.0	11.8	12.1	2.5	9.4	8.7	4.0	1.7	6.3	6.9	4.2	4.0	2.7	5.9	2.8	6.7	10.9	4.3	11.1	4.5	9.2	5.1	3.6	9.1	5.9	6.0	7.6	5.9	3.1	3.6	2.6	10.9	3.4	7.7	7.7	4.1	9.4	6.6	16.7	6.1	10.0	11.8	2.9	4.4	7.7	4.7	5.3	8.9	8.0	4.2	5.5	4.0	8.7	2.5	7.2	3.8	0.6	1.4	5.0	10.8	1.4	4.1	5.2	9.9	5.9	8.0	5.2	4.8	4.9	3.9	6.9	5.5	0.0	3.4	5.4	4.3	4.2	3.9	14.8	0.0	12.0	4.5	0.0	7.9	2.7	10.0	4.2	101.0	4.6	3.2	0.0	4.5	3.0	3.1	4.0	2.3	5.9	5.9	3.2	7.5	4.9	6.3	64.2	2.3	4.3	0.0	1.0	3.6	4.8	4.0	0.0	2.5	4.5	9.6	0.0	3.9	11.9	13.8	3.1	5.8	2.5	4.9	2.7
ZSCAN5B	"ZNF371, ZNF495B"	ENSG00000197213	"Zinc finger and SCAN domain containing 5B"	A6NJL1	19	56189570-56197920	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.5;testis: 6.1"	"Cell type enriched"	"Detected in single"	11	"Spermatogonia: 5.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.5;plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.7;hTCEpi: 1.3"									"HPA043123, HPA046836, HPA059494, HPA060667"	Uncertain		Uncertain	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA043123: AB_2678328, HPA046836: AB_2679832, HPA059494: AB_2684038, HPA060667: "	"unprognostic (4.73e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.15e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.83e-2)"	0.0	0.0	0.7	0.0	1.2	0.2	0.0	0.0	0.3	0.0	0.0			0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1		0.0	0.0	0.1	0.0	0.1		0.1	0.0		0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	6.1			0.0		0.0	0.0	0.0	0.0	1.5	0.1	0.4	0.0	0.2	0.1	0.0	0.0	0.8	0.3	0.4	0.3	0.2	0.5	0.5	0.0	0.6	0.0	0.0	1.0	0.1	0.9	0.1	0.1	0.2	0.0	0.0	0.0	1.7	0.9	0.0	0.3	0.0	0.6	0.3	0.4	1.3	0.0	0.0	0.1	0.2	0.5	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.9	0.0	0.3	0.0	0.4	0.0	1.0	0.0	0.4	0.0	0.3	0.0	0.6	0.8	0.3	0.0	0.6	0.0	0.1	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.7	0.0	0.0	0.0	0.0	0.0
ZSCAN5C	"ZNF495C, ZSCAN5CP"	ENSG00000204532	"Zinc finger and SCAN domain containing 5C"	A6NGD5	19	56202301-56209452	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in single"		"testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"PC-3: 1.7"									"HPA041263, HPA043123, HPA046836, HPA060667"	Uncertain		Uncertain	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: "	"unprognostic (3.74e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.56e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.53e-3)"	0.4	0.0	0.1	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.1			0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.0		0.1	0.0	0.0	0.0	0.0		0.1	0.0		0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	1.0			0.3		0.0	0.7	0.0	0.9	0.3	0.0	0.3	0.0	0.7	0.2	0.2	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.9	0.0	0.4	0.7	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.4	0.9	0.2	1.7	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.8	0.0	0.0	0.2	0.4	0.7	0.7	0.3	0.0	0.3	0.4	0.4	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.6	0.3	0.7	0.7	0.7	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0